Ovarian Cancer Trial, Recruiting NCT07167433 Sponsor: AstraZeneca Condition: Ovarian Cancer
Back to Ovarian Cancer

Ovarian Cancer Trial, Recruiting

NCT07167433
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People diagnosed with ovarian cancer for the first time (at any stage from IA to IVB), or whose ovarian cancer has come back or not gone away, with a diagnosis from January 2021 onwards
  • People with any type of ovarian cancer tissue (no restriction on the specific cancer cell type)

Who may not be able to join:

  • People whose ovarian tumour has been classified as "borderline" (a type that is not fully cancerous)
  • People who are currently pregnant
  • People who have had another separate cancer diagnosed at the same time, or a different primary cancer diagnosed within the last 5 years (with the exception of thyroid cancer or certain common skin cancers that are not melanoma)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1-877-240-9479

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
19 September 2025
Est. completion
30 June 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

Description of socio-demographic characteristics; Description of pathological characteristics; Description of treatment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov